Cadence discovery: study protocol for a dose-finding and mechanism of action clinical trial of sodium benzoate in people with treatment-refractory schizophrenia
Abstract Background Schizophrenia is a persistent psychotic disorder often accompanied by severe disability and premature mortality. New pharmacological treatments are urgently needed. Sodium benzoate, a common food preservative holds potential to be an effective, accessible treatment for schizophre...
Hauptverfasser: | , , , , , , , , , , , , , |
---|---|
Format: | Artikel |
Sprache: | English |
Veröffentlicht: |
BMC
2021-12-01
|
Schriftenreihe: | Trials |
Schlagworte: | |
Online Zugang: | https://doi.org/10.1186/s13063-021-05890-6 |